The IRB Office is revising and updating current policies in order to reflect recent changes to the Common Rule. All policies will be approved by quorum of the convened IRB. Once approved they will be communicated to the university community and added to this manual.
1-1. IRB Jurisdiction and Authority
1-2. IRB Membership, Roles, and Responsibilities
1-3. Investigator Responsibilities
1-4 Conflicts of Interest (CoI) [revisions in progress]
1-5. IRB Reliance Agreements [revisions in progress]
1-6. IRB Office SOPs [revisions in progress]
1-7. Generation, Use, and Revisions of Standard Operating Procedures
2-1. IRB Authorized Reviewers, Levels of IRB Review, and Decisions
2-2. Protocol Revisions, Annual Status of Research, and Study Closure
2-3 Unanticipated Problems, Adverse Events, and Investigational New Drug Safety
2-4 Non-Compliance and the Suspension/Termination of Approved Research
2-5 Appeals of IRB Actions or Determinations
4-2 Translations for Studies conducted in a Language other than English
4-3 Protection of Vulnerable Populations
4-4 Research Involving Deception
4-5 Humanitarian Use Devices (HUD) [revisions in progress]
4-6 Emergency Use [revisions in progress]
4-7 Recordkeeping and the Privacy/Confidentiality of Research Records
5 Post-Approval Monitoring of Research
6-1 Banking of Biospecimens/Data [revisions in progress]
6-2 Return of Research Results [revisions in progress]
HIPAA Research Policy No. 1: General
HIPAA Research Policy No. 2: IRB Waiver of HIPAA Authorization
HIPAA Research Policy No. 3: De-identified and Decedent Information
HIPAA Research Policy No. 4: Reviews Preparatory to Research
HIPAA Research Policy No. 5: Accounting of Disclosure
HIPAA Research Policy No. 6: Guidance on Research at Outside Entities
Note: The above HIPAA policies were presented by the NSU Office of Health Care Compliance and approved by the NSU IRB. All questions regarding the HIPAA policies should be directed to the NSU Office of Health Care Compliance.